mail unicampaniaunicampania webcerca

    Mirko CORTESE

    Insegnamento di MOLECULAR MICROBIOLOGY

    Corso di laurea magistrale in MOLECULAR BIOTECHNOLOGY

    SSD: BIO/19

    CFU: 6,00

    ORE PER UNITÀ DIDATTICA: 48,00

    Periodo di Erogazione: Primo Semestre

    Italiano

    Testi di riferimento



    Obiettivi formativi



    Prerequisiti



    Metodologie didattiche



    Metodi di valutazione



    Altre informazioni



    English

    Teaching language

    English

    Contents

    Molecular virology, viral replication cycle, SARS-CoV-2. Interaction between bacterial and viral pathogens with animal cells and tissues. Quorum sensing. Antivirals and vaccines.

    Textbook and course materials

    Scientific research articles and reviews provided by the lecturer

    Course objectives

    The objective of this course is to provide an overview of cellular microbiology applied to human health. Moreover, the course will give an overview of recent advances in development of antivirals and vaccines to prevent bacterial and viral diseases.

    Prerequisites

    Knowledge acquired with a Bachelor degree in Biotechnology or in Biology, or equivalent academic degrees.

    Teaching methods

    Frontal lessons and seminars

    Evaluation methods

    Verification of learning consist in an oral exam.

    Other information

    Supplementary material will be provided during the course. The lecturer will receive students during the office hours indicated or on request submitted via e-mail

    Course Syllabus

    FIRST PART
    Molecular virology, viruses classification, methods in virology. Viral replication cycle, positive-strand RNA viruses, Coronaviridae and SARS-CoV-2. Host-virus interactions. Imaging of viruses, electron microscopy

    SECOND PART
    Cross-talk among microbial cells: quorum sensing in Gram+ and Gram-. Microbial pathogenesis:
    development of multidrug resistance, efflux pumps in pathogenic mycobacteria.

    THIRD PART
    Development and discovery of therapeutics. Antivirals and monoclonal antibodies. Vaccines: correlate of protection, immune response to vaccine. History of vaccine development: inactivated and attenuated vaccines, glycoconjugate vaccines, reverse vaccinology, structural vaccinology. Novel technologies: vectored vaccines, mRNA vaccines, SARS-CoV-2 vaccines.

    facebook logoinstagram buttonyoutube logotype